Ketone monoester increases circulating levels of LEAP2 and decreases appetite in healthy men
Open Access
- 16 March 2023
- journal article
- letter
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 25 (7) , 2023-2027
Abstract
No abstract availableFunding Information
- Danish Diabetes and Endocrine Academy (NNF17SA0031406)
- Novo Nordisk Fonden (NNF18CC0034900)
This publication has 11 references indexed in Scilit:
- Acute ketosis inhibits appetite and decreases plasma concentrations of acyl ghrelin in healthy young menDiabetes, Obesity and Metabolism, 2021
- Identification and Metabolic Profiling of a Novel Human Gut-derived LEAP2 FragmentThe Journal of Clinical Endocrinology & Metabolism, 2020
- LEAP2 changes with body mass and food intake in humans and miceJournal of Clinical Investigation, 2019
- LEAP2 Is an Endogenous Antagonist of the Ghrelin ReceptorCell Metabolism, 2018
- A Ketone Ester Drink Lowers Human Ghrelin and AppetiteObesity, 2017
- Metabolism of ketone bodies during exercise and training: physiological basis for exogenous supplementationThe Journal of Physiology, 2016
- The hypophagic response to heat stress is not mediated by GPR109A or peripheral β-OH butyrateAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2016
- GhrelinMolecular Metabolism, 2015
- Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysisEuropean Journal of Endocrinology, 2005
- Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studiesInternational Journal of Obesity, 2000